The document outlines the standard operating procedure for sampling, testing, and releasing or rejecting finished products. It describes the steps taken by quality control personnel, including receiving sampling requests, collecting and labeling samples, distributing samples for analysis, testing samples according to procedures, reviewing results, and releasing or rejecting batches based on specifications. Key steps involve sampling from containers, analyzing samples in the chemical and instrument labs, approving results, and recording the final status of batches.
Complaints in Quality Management SystemMayuriMore15
Complaints evaluation and handling, Investigation and Determination, CAPA and Return and Recall of products in Quality Management system in pharmaceutical or any industry.
In this slide contains introduction, qualification, preventive maintenance, requalification method.
Presented by: Malarvannan M (Department of pharmaceutical analysis).RIPER, anantapur
Complaints in Quality Management SystemMayuriMore15
Complaints evaluation and handling, Investigation and Determination, CAPA and Return and Recall of products in Quality Management system in pharmaceutical or any industry.
In this slide contains introduction, qualification, preventive maintenance, requalification method.
Presented by: Malarvannan M (Department of pharmaceutical analysis).RIPER, anantapur
Qualification of Dissolution Test Apparatus and Validation of Utility System this presentation will help to enhance your knowledge in validation and qualification area.
Review of Quality Control Record and Analytical Data by Dr. A. AmsavelDr. Amsavel A
Review of Quality Control Record and Analytical Data
Objective and Requirement for Analytical data review
Role of Analyst and reviewer,
Procedure and checklist for review of records/data
Review of traceable /associated documents
Review of calibration, Reference standard record, sampling reports,
Review of Audit trail
Role of Analyst & Reviewer
Review of chromatograms& audit trail,
Data Integrity & Good Record Practice
FDA Citations
The presentation was an overview of the GMP regulations specific to cleaning validation for medicine manufacturers. New guidelines for Health Based Exposure Limits were discussed along with common GMP deficiencies observed during TGA inspections.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with qualifications of HPLC which is the " High Performance Liquid Chromatography".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
After deciding you want artificial grass for your school you have to decide which type of artificial grass you want. Our recommendation: XPlay or Ultra, two qualities from Royal
Grass®.
www.royalgrass.com
enjoy perfection
a new style installation manual for those who would like some tips and pointers on Royal Grass artificial grass installation in their garden or other application .
ROYAL GRASS
ENJOY PERFECTION
www.royalgrass.com
Qualification of Dissolution Test Apparatus and Validation of Utility System this presentation will help to enhance your knowledge in validation and qualification area.
Review of Quality Control Record and Analytical Data by Dr. A. AmsavelDr. Amsavel A
Review of Quality Control Record and Analytical Data
Objective and Requirement for Analytical data review
Role of Analyst and reviewer,
Procedure and checklist for review of records/data
Review of traceable /associated documents
Review of calibration, Reference standard record, sampling reports,
Review of Audit trail
Role of Analyst & Reviewer
Review of chromatograms& audit trail,
Data Integrity & Good Record Practice
FDA Citations
The presentation was an overview of the GMP regulations specific to cleaning validation for medicine manufacturers. New guidelines for Health Based Exposure Limits were discussed along with common GMP deficiencies observed during TGA inspections.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with qualifications of HPLC which is the " High Performance Liquid Chromatography".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
After deciding you want artificial grass for your school you have to decide which type of artificial grass you want. Our recommendation: XPlay or Ultra, two qualities from Royal
Grass®.
www.royalgrass.com
enjoy perfection
a new style installation manual for those who would like some tips and pointers on Royal Grass artificial grass installation in their garden or other application .
ROYAL GRASS
ENJOY PERFECTION
www.royalgrass.com
Seven Wonders of Concrete: Vote for your favourite projectLafarge
Lafarge is a partner of the France Pavilion at the Shanghai 2010 World Expo. The Expo is focusing on themes of urbanization, architecture and sustainable construction. The "Seven Wonders of Concrete" presentation illustrates the most spectacular technological initiatives in terms of building materials through symbolic structures. From June 7th, come and vote on our Facebook page for your favorite structure. The structure which wins the most likes will be named Top Wonder of Concrete!
This presentation material is concerned with research results for Ultra High Performance Concrete. The research was focused on the behavior of shrinkage in UHPC.
A UHPC (ultra high performance concrete) presentation projects.Nolan Mayrhofer
UHPC presentation featuring select international Ductal projects. This is an in depth look at the types of architectural projects UHPC is best suited for.
Pharmaceutical Sampling Strategy, Compliance and Future TrendsExL Pharma
With increased use and scrutiny of drug samples by pharmaceutical industry, this presentation outlines some current updates, compliance issues and future trends. An effective drug sampling program can really make an impact on a pharmaceutical company brand and lead to increased patient starts.
presentation of sampling , testing ,release and rejection of Raw materialsshaik malangsha
I hope this ppt would be help to improve & make aware about better sampling , testing ,release and rejection of Raw materials . I believe if once ill go through this ppt it ill defiantly help to improve our RM procedure. If any clarifications pls. mail me at shkrahul42@gmail.com
This is a practical session during vaccine and serum course. A course for the fourth year undergraduate students (Pharmacology domain) at department of virology, faculty of veterinary medicine, Cairo University.
Documentation with respect to release of finished pharmaceutical productMadhuraNewrekar
Documentation is a crucial part of the quality assurance system and is needed in every aspect of pharmaceutical manufacturing. Important documentation with respect to final product release in pharmaceutical industry is explained in brief.
GMP helps in providing quality standard product. Subpart - E is related to Control of Components and Drug product containers and closures. Subpart - F is related to Production and Process control.
GMP Sub Part - "E" gives valuable information regarding Control of components and Product containers and closures during pharmaceutical manufacturing while Sub Part - "F" gives ideas about pharmaceutical production and process control. Very helpful to pharma professionals.
Pharmacovigilance role through investigating Out of Specification (OOS) for F...Mohamed Raouf
Pharmacovigilance role in Investigating OOS for Finished Product on the Stability Program through Health Hazard Assessment & Post monitoring and effectiveness check.
I am uploading this GMP presentation to make aware who are working in pharma and help to maintain high standards in products manufacturing .
GMP Vs cGMP: It is my understanding that , Ultimately GMP & cGMP both the aim is same, means to prevention of the product from bad quality entering the market to endover peoples's life.
GMP applies to pharmaceutical and healthcare products and help to maintain high standards in these products.
cGMP is to remind accepting countries that all guidelines must be followed with latest and current production processes i.e employ technologies and systems which are up-to-date in order to comply with the regulation.
FDA (Food and Drug Administration) included the word “current” to ensure that regulated firms use the most current Good Manufacturing Practices (I believe that some firms would actually use outdated versions of the GMP’s to manufacture regulated products.
(the FDA have made their standards immediately identifiable i.e cGMP; Other international bodies such as the ICH, WHO use the term GMP, as do Canada, Japan and the EMEA (European authority). In FDA view cGMP means following 21 CFR 210 and 211 and no other.)
1. SAMPLING, TESTING AND
RELEASE / REJECTION OF
FINISHED PRODUCT
Presented by
Malangsha
shkrahul42@gmail.com
1
SAMPLING, TESTING AND
RELEASE / REJECTION OF
FINISHED PRODUCT
Presented by
Malangsha
shkrahul42@gmail.com
2. Quality Control Department shall receive "Sampling
request" from the production department, as intimation for
product sampling.
Executive – QC shall enter the details in the finished product
inward register as per the sampling request and assigns an
Analytical Reference Number (A.R.No.) as per SOP.
Executive-QC shall prepare sample labels and approach
production department along with Self sealed polyethylene bags,
sampling devices (SS Spoons/Scoops/Spatulas) and sampling
check list, to proceed for sampling.
Sampling devices shall be dedicated and product specific.
Quality Control Department shall receive "Sampling
request" from the production department, as intimation for
product sampling.
Executive – QC shall enter the details in the finished product
inward register as per the sampling request and assigns an
Analytical Reference Number (A.R.No.) as per SOP.
Executive-QC shall prepare sample labels and approach
production department along with Self sealed polyethylene bags,
sampling devices (SS Spoons/Scoops/Spatulas) and sampling
check list, to proceed for sampling.
Sampling devices shall be dedicated and product specific.
2
Quality Control Department shall receive "Sampling
request" from the production department, as intimation for
product sampling.
Executive – QC shall enter the details in the finished product
inward register as per the sampling request and assigns an
Analytical Reference Number (A.R.No.) as per SOP.
Executive-QC shall prepare sample labels and approach
production department along with Self sealed polyethylene bags,
sampling devices (SS Spoons/Scoops/Spatulas) and sampling
check list, to proceed for sampling.
Sampling devices shall be dedicated and product specific.
Quality Control Department shall receive "Sampling
request" from the production department, as intimation for
product sampling.
Executive – QC shall enter the details in the finished product
inward register as per the sampling request and assigns an
Analytical Reference Number (A.R.No.) as per SOP.
Executive-QC shall prepare sample labels and approach
production department along with Self sealed polyethylene bags,
sampling devices (SS Spoons/Scoops/Spatulas) and sampling
check list, to proceed for sampling.
Sampling devices shall be dedicated and product specific.
3. Executive-QC along with QA representative shall check the
under test labels on the containers with respect to sampling
request.
In case of discrepancy, the same shall be informed to
production incharge to resolve the issue.
Executive-QC shall wear suitable safety devices and open all the
containers.
In the case of hygroscopic materials container wise shall be
opened, sampled and closed immediately under nitrogen
atmosphere.
3
Executive-QC along with QA representative shall check the
under test labels on the containers with respect to sampling
request.
In case of discrepancy, the same shall be informed to
production incharge to resolve the issue.
Executive-QC shall wear suitable safety devices and open all the
containers.
In the case of hygroscopic materials container wise shall be
opened, sampled and closed immediately under nitrogen
atmosphere.
4. Executive-QC shall check the physical appearance of the
material and mix the contents thoroughly within the container
by sampling devices.
If the physical appearance of the material is same in all
the containers, then all samples shall be collected into a self
sealed polythene bag.
In case of discrepancy of physical appearance, the same
shall be in formed to Head- QC and QA.
All observations of sampling shall be recorded in "Finished
Product Sampling check list" .
4
Executive-QC shall check the physical appearance of the
material and mix the contents thoroughly within the container
by sampling devices.
If the physical appearance of the material is same in all
the containers, then all samples shall be collected into a self
sealed polythene bag.
In case of discrepancy of physical appearance, the same
shall be in formed to Head- QC and QA.
All observations of sampling shall be recorded in "Finished
Product Sampling check list" .
5. Sampling shall be done from all the containers in such away that
the total quantity shall be sufficient for three complete analyses
(approximately 170 g).
Quantity justification for Finished product:
•60 g for chemical & instrumental analysis
(i.e., 55g for chemical and 5gm for instrumental analysis).
• 60 g for Retention sample (30 g x 2).
• 5Og for Microbiology (if required).
In case of additional tests /market samples, additional
quantity shall be sampled and the same shall be recorded.
5
Sampling shall be done from all the containers in such away that
the total quantity shall be sufficient for three complete analyses
(approximately 170 g).
Quantity justification for Finished product:
•60 g for chemical & instrumental analysis
(i.e., 55g for chemical and 5gm for instrumental analysis).
• 60 g for Retention sample (30 g x 2).
• 5Og for Microbiology (if required).
In case of additional tests /market samples, additional
quantity shall be sampled and the same shall be recorded.
6. Post sampling, batch containers shall be sealed immediately
and seal numbers shall be recorded in BPCR by the Assistant-
Production and Executive-QC shall affix "Sampled" labels on
the containers adjacent to under test Labels.
Sampling Executive shall check the integrity of the sampling
devices after sampling.
Collected composite samples shall be brought to QC and
distributed for chemical/instrument lab/Retention sample and
microbiology analysis.
Retention samples shall be packed as per market simulating
conditions and preserved immediately.
6
Post sampling, batch containers shall be sealed immediately
and seal numbers shall be recorded in BPCR by the Assistant-
Production and Executive-QC shall affix "Sampled" labels on
the containers adjacent to under test Labels.
Sampling Executive shall check the integrity of the sampling
devices after sampling.
Collected composite samples shall be brought to QC and
distributed for chemical/instrument lab/Retention sample and
microbiology analysis.
Retention samples shall be packed as per market simulating
conditions and preserved immediately.
7. The QC Analyst shall test the samples as per respective standard
test procedures.
All the raw data generated during analysis shall be recorded in
the respective protocol.
Calculations / observations /chromatograms and reports
related to analytical data shall be attached with the analytical
protocol.
Section head shall review the raw data thoroughly and upon
execution forwards to Head-QC/Deputy for approval.
Head-QC/Deputy shall verify the data randomly, approves
the document and forward the protocol to QA.
7
The QC Analyst shall test the samples as per respective standard
test procedures.
All the raw data generated during analysis shall be recorded in
the respective protocol.
Calculations / observations /chromatograms and reports
related to analytical data shall be attached with the analytical
protocol.
Section head shall review the raw data thoroughly and upon
execution forwards to Head-QC/Deputy for approval.
Head-QC/Deputy shall verify the data randomly, approves
the document and forward the protocol to QA.
8. QA shall further review and forward the batch release
certificate to QC.
Finally QC shall prepare the "Release for Further Processing"
labels and affix on under test labels of the containers.
If the case of failure in quality parameters, OOS (Out of
specification) shall be initiated and investigation shall be
carried out.
Based on the investigation recommendation, status of the
material shall be concluded.
The final status of the material shall be recorded in
concerned inward registers along with date of release.
8
QA shall further review and forward the batch release
certificate to QC.
Finally QC shall prepare the "Release for Further Processing"
labels and affix on under test labels of the containers.
If the case of failure in quality parameters, OOS (Out of
specification) shall be initiated and investigation shall be
carried out.
Based on the investigation recommendation, status of the
material shall be concluded.
The final status of the material shall be recorded in
concerned inward registers along with date of release.
9. If the investigation concludes with rejection, "Rejected labels"
shall be affixed on the batch containers.
Additional tests (as per customer/Market/Regulatory
requirements) shall be performed and raw data shall be recorded
in the additional raw data sheet.
Such additional test results shall be captured along with batch
certificate of analysis.
9
If the investigation concludes with rejection, "Rejected labels"
shall be affixed on the batch containers.
Additional tests (as per customer/Market/Regulatory
requirements) shall be performed and raw data shall be recorded
in the additional raw data sheet.
Such additional test results shall be captured along with batch
certificate of analysis.